Latin America is the region with the third most AIDS-related cryptococcal meningitis infections globally. Highly active antiretroviral therapy (HAART) has reduced the number of infections; however, the number of deaths and the case-fatality rate continues to be unacceptable. In this review, we focus on the burden of AIDS-related cryptococcosis in Latin America and discuss potential strategies to reduce early mortality from Cryptococcus. In this review, we highlight the importance of: (1) earlier HIV diagnosis and HAART initiation with retention-in-care to avoid AIDS; (2) pre-HAART cryptococcal antigen (CRAG) screening with preemptive fluconazole treatment; (3) better diagnostics (e.g. CRAG testing); and (4) optimal treatment with aggressive management of intracranial pressure and induction therapy with antifungal combination. Implementation of these strategies can reduce cryptococcal-related deaths, improve care, and reduce healthcare costs. © 2013 Elsevier Editora Ltda.
CITATION STYLE
Vidal, J. E., Penalva de Oliveira, A. C., Dauar, R. F., & Boulware, D. R. (2013, May). Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America. Brazilian Journal of Infectious Diseases. https://doi.org/10.1016/j.bjid.2012.10.020
Mendeley helps you to discover research relevant for your work.